Nonalcoholic fatty liver disease across ethno-racial groups: Do Asian-American adults represent a new at-risk population?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 3, 2011, Pages 501-509

  Tabibian, James H ^a,b   Lazo, Mariana ^c   Durazo, Francisco A ^b   Yeh, Hsin Chieh ^a,c   Tong, Myron J ^b   Clark, Jeanne M ^a,c  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cirrhosis; Ethnic groups; Fatty liver; Histopathology

Indexed keywords

ADULT; ARTICLE; ASIAN AMERICAN; BODY MASS; CAUCASIAN; DISEASE SEVERITY; ETHNIC AND RACIAL GROUPS; FATTY LIVER; FEMALE; HEPATITIS; HIGH RISK POPULATION; HISPANIC; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; RISK FACTOR; WEIGHT;

EID: 79951624285     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06443.x     Document Type: Article

References (34)

1. Browning JD, Szczepaniak LS, Dobbins R etal. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40: 1387-95.
2. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am. J. Gastroenterol. 2003; 98: 960-7.
3. Weston SR, Leyden W, Murphy R etal. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005; 41: 372-9.
4. Angulo P. GI epidemiology: nonalcoholic fatty liver disease. Aliment. Pharmacol. Ther. 2007; 25: 883-9.
5. Willner IR, Waters B, Patil SR, Reuben A, Morelli J, Riely CA. Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am. J. Gastroenterol. 2001; 96: 2957-61.
6. Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, KL G, Asia-Pacific Working Party on NAFLD. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J. Gastroenterol. Hepatol. 2007; 22: 788-93.
7. Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, JD S, Asia-Pacific Working Party on NAFLD. Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. J. Gastroenterol. Hepatol. 2007; 22: 778-87.
8. Seidell JC. Obesity, insulin resistance and diabetes-a worldwide epidemic. Br. J. Nutr. 2000; 83 (Suppl. 1): S5-8.
9. Struben VM, Hespenheide EE, Caldwell SH. Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am. J. Med. 2000; 108: 9-13.
10. Caldwell SH, Harris DM, Patrie JT, Hespenheide EE. Is NASH underdiagnosed among African Americans? Am. J. Gastroenterol. 2002; 97: 1496-500.
11. Kallwitz ER, Kumar M, Aggarwal R etal. Ethnicity and nonalcoholic fatty liver disease in an obesity clinic: the impact of triglycerides. Dig. Dis. Sci. 2008; 53: 1358-63.
12. Nonalcoholic SS. Fatty liver disease and obesity. Nutr. Clin. Pract. 2007; 22: 1-10.
13. Kemmer N, Neff GW. Ethnic variations in chronic liver diseases. Dig. Dis. Sci. 2008; 53: 1339-44.
14. Perry AC, Applegate EB, Jackson ML etal. Racial differences in visceral adipose tissue but not anthropometric markers of health-related variables. J. Appl. Physiol. 2000; 89: 636-43.
15. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999; 94: 2467-74.
16. International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009; 32: 1327-34.
17. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 1994; 107: 1103-9.
18. Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A, Asia-Pacific Working Party for NAFLD. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J. Gastroenterol. Hepatol. 2007; 22: 794-800.
19. Prashanth M, Ganesh HK, Vima MV etal. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. J. Assoc. Physicians India 2009; 57: 205-10.
20. Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ, Nash Clinical Research Network. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 2009; 7: 1104-12.
21. Georgescu EF. Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option? Adv. Ther. 2008; 25: 1141-74.
22. Park KS, Lee YS, Park HW, Seo SH etal. Factors associated or related to pathological severity of nonalcoholic fatty liver disease. Korean J. Intern. Med. 2004; 19: 19-26.
23. Seo S, Maganti K, Khehra M etal. De novo nonalcoholic fatty liver disease after liver transplantation. Liver Transpl. 2007; 13: 844-7.
24. Rafiq N, Bai C, Fang Y etal. Long-term follow-up of patients with nonalcoholic fatty liver. Clin. Gastroenterol. Hepatol. 2009; 7: 234-8.
25. Choi DH, Park MO, Kang CD, Lee SJ, Lee JW, Cho BR. The relationship between nonalcoholic fatty liver disease and coronary artery disease; a prospective case-control study in a single center [abstract]. Hepatology 2009; 50: 764A.
26. Rouvman Y, Alon M, Dvorin I, Deitzman M, Assy N. Fatty liver predict the presence of coronary plaques and early atherosclerosis independently by visceral fat accumulation [abstract]. Hepatology 2009; 50: 768A.
27. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356-62.
28. Fan JG, Peng YD. Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies. Hepatobiliary Pancreat. Dis. Int. 2007; 6: 572-8.
29. Aouizerat BE, Bambha K, Unalp-Arida A, Ferrell L, Bass NM. Genetic variation in hormone sensitive lipase and adiponectin confers susceptibility to nonalcoholic fatty liver disease [abstract]. Hepatology 2009; 50: 768A.
30. Younossi ZM, Jarrar M, Nugent C etal. A novel diagnostic biomarker panel for obesity-related nonalcoholic steatohepatitis (NASH). Obes. Surg. 2008; 18: 1430-7.
31. Bambha K, Aouizerat BE, Unalp-Arida A, Ferrell L, Bass NM. Genetic variation in adiponectin confers susceptibility to nonalcoholic fatty liver disease in Latino Caucasians [abstract]. Hepatology 2009; 50: 771-772A.
32. Muñoz LE, Cordero P, Torres L, Sauceda AY, Flores JP, Segura JJ. Adipokines in a group of Mexican patients with nonalcoholic steatohepatitis. Ann. Hepatol. 2009; 8: 123-8.
33. Miele L, Vallone S, Cefalo C etal. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J. Hepatol. 2009; 51: 778-86.
34. Hossain N, Afendy A, Stepanova M etal. Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 2009; 7: 1224-9. 1229.e1-2.